Ben Mumford, MS, is a Senior Manager, Business Development & Licensing in Memorial Sloan Kettering Cancer Center’s Office of Entrepreneurship and Commercialization (OEC). He previously served as a senior licensing manager. He is a member of OEC’s Life Sciences Partnering & Business Development group and manages MSK’s Technology Development Investment Fund (TDIF) and its related programs.
Prior to joining MSK in 2021, Ben was a research associate at several biotechnology firms, including Cellectis’ Immuno-oncology innovation group; Inzen Therapeutics’ Platform Development team; EpiBone’s pre-clinical development group; and Nomocan Pharmaceutical’s pre-clinical research team.
Ben received an M.S. in Biotechnology from New York University and holds a B.S. in Biochemistry from the University of Kansas.